Black Rose Industries FY26 Audited Results Published; Net Profit ₹2,249.61 Lakhs, Dividend of ₹1.25 Recommended
Black Rose Industries approved and published its FY26 audited standalone and consolidated financial results, reporting a standalone net profit of ₹2,249.61 lakhs and revenue from operations of ₹32,301.40 lakhs. The board recommended a final dividend of ₹1.25 per equity share and approved key corporate appointments including the re-appointment of Whole-time Directors and a new Company Secretary. Results were published in Business Standard and Mumbai Lakshadeep on May 15, 2026, pursuant to Regulation 47 of SEBI LODR.

*this image is generated using AI for illustrative purposes only.
Black Rose Industries held its Board of Directors meeting on May 13, 2026, and approved the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. Subsequently, pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published an extract of its audited financial results (standalone and consolidated) in Business Standard (English Edition) and Mumbai Lakshadeep (Marathi Edition) on May 15, 2026. The statutory auditors, M/s. M M Nissim & Co LLP, Chartered Accountants (Firm Regn. No. 107122W/W100672), issued an unmodified audit opinion on the financial results.
Standalone Financial Performance
The company's standalone financials for the year ended March 31, 2026, reflect a moderation in revenue alongside a decline in net profit compared to the prior year. The following table presents the key standalone financial metrics:
| Metric: | Q4 FY26 (Audited) | Q3 FY26 (Unaudited) | Q4 FY25 (Audited) | FY26 (Audited) | FY25 (Audited) |
|---|---|---|---|---|---|
| Revenue from Operations (₹ Lakhs): | 10,404.15 | 7,514.70 | 8,242.37 | 32,301.40 | 33,734.12 |
| Other Income (₹ Lakhs): | 73.74 | 71.46 | 56.92 | 282.43 | 897.59 |
| Total Revenue (₹ Lakhs): | 10,477.89 | 7,586.16 | 8,299.29 | 32,583.83 | 34,631.71 |
| Total Expenses (₹ Lakhs): | 9,249.20 | 6,992.10 | 7,504.74 | 29,573.10 | 31,208.17 |
| Profit Before Tax (₹ Lakhs): | 1,228.69 | 594.06 | 769.19 | 3,010.73 | 3,398.18 |
| Net Profit After Tax (₹ Lakhs): | 941.59 | 440.78 | 571.80 | 2,249.61 | 2,658.96 |
| Total Comprehensive Income (₹ Lakhs): | 945.90 | 440.84 | 571.93 | 2,249.65 | 2,659.33 |
| Basic EPS (₹): | 1.85 | 0.86 | 1.12 | 4.41 | 5.21 |
| Diluted EPS (₹): | 1.85 | 0.86 | 1.12 | 4.41 | 5.21 |
On a standalone basis, paid-up equity share capital stood at ₹510.00 lakhs (face value ₹1 per share), while other equity excluding revaluation reserve was ₹16,418.02 lakhs as at March 31, 2026, compared to ₹14,754.88 lakhs as at March 31, 2025. During the quarter, the company recognised an additional ₹33.43 lakhs in the defined benefit obligation for gratuity towards past service cost, charged under employee benefit expenses in accordance with India's new Labour Codes and Ind AS 19.
Standalone Balance Sheet Highlights
The standalone statement of assets and liabilities as at March 31, 2026, reflects the following position (₹ in Lakhs):
| Parameter: | 31-03-2026 (Audited) | 31-03-2025 (Audited) |
|---|---|---|
| Total Non-Current Assets: | 5,486.05 | 5,009.05 |
| Total Current Assets: | 15,289.56 | 16,235.06 |
| Total Assets: | 20,775.61 | 21,244.11 |
| Total Equity: | 16,928.02 | 15,264.88 |
| Non-Current Liabilities: | 561.61 | 455.45 |
| Current Liabilities: | 3,285.98 | 5,523.78 |
| Total Equity and Liabilities: | 20,775.61 | 21,244.11 |
Standalone Cash Flow Summary
The standalone cash flow statement for the year ended March 31, 2026, showed a significant improvement in operating cash generation (₹ in Lakhs):
| Cash Flow Item: | FY26 (Audited) | FY25 (Audited) |
|---|---|---|
| Net Cash from Operating Activities: | 4,457.98 | (1,214.90) |
| Net Cash from Investing Activities: | (2,557.81) | 1,735.63 |
| Net Cash from Financing Activities: | (1,650.00) | (749.85) |
| Net Increase/(Decrease) in Cash: | 250.17 | (229.13) |
| Cash & Equivalents – End of Period: | 292.84 | 42.67 |
Consolidated Financial Performance
The consolidated results include the financial results of wholly owned subsidiary B.R. Chemicals Co. Limited, whose business operations have been classified as discontinued operations in accordance with Ind AS 105, following the Board's decision to initiate steps for the closure, sale, or transfer of 100% of its shareholding in the subsidiary. The key consolidated financial metrics are presented below:
| Metric: | Q4 FY26 (Audited) | Q3 FY26 (Audited) | Q4 FY25 (Audited) | FY26 (Audited) | FY25 (Audited) |
|---|---|---|---|---|---|
| Revenue from Operations (₹ Lakhs): | 10,404.15 | 7,514.70 | 8,242.37 | 32,301.40 | 33,734.12 |
| Total Revenue (₹ Lakhs): | 10,477.89 | 7,586.16 | 8,299.29 | 32,583.83 | 34,068.53 |
| Total Expenses (₹ Lakhs): | 9,249.20 | 6,992.10 | 7,504.74 | 29,573.10 | 31,208.16 |
| Profit Before Tax – Continuing Operations (₹ Lakhs): | 1,228.69 | 594.06 | 794.55 | 3,010.73 | 2,860.37 |
| Net Profit – Continuing Operations (₹ Lakhs): | 941.59 | 440.78 | 597.15 | 2,249.61 | 2,121.15 |
| Profit/(Loss) – Discontinued Operations (₹ Lakhs): | (0.60) | (0.89) | 9.45 | (7.19) | (1.32) |
| Net Profit – Continuing & Discontinued (₹ Lakhs): | 940.99 | 439.89 | 606.60 | 2,242.42 | 2,119.83 |
| Total Comprehensive Income (₹ Lakhs): | 946.59 | 438.27 | 608.04 | 2,244.15 | 2,155.82 |
| Basic EPS – Continuing Operations (₹): | 1.85 | 0.86 | 1.17 | 4.41 | 4.16 |
| Diluted EPS – Continuing Operations (₹): | 1.85 | 0.86 | 1.17 | 4.41 | 4.16 |
The discontinued subsidiary reported total income of ₹1.39 lakhs, expenses of ₹8.58 lakhs, a loss of ₹7.19 lakhs, and a comprehensive loss of ₹5.50 lakhs for the year ended March 31, 2026. Consolidated other equity excluding revaluation reserve stood at ₹16,433.61 lakhs as at March 31, 2026, compared to ₹14,775.97 lakhs as at March 31, 2025.
Consolidated Balance Sheet Highlights
The consolidated statement of assets and liabilities as at March 31, 2026, is summarised below (₹ in Lakhs):
| Parameter: | 31-03-2026 (Audited) | 31-03-2025 (Audited) |
|---|---|---|
| Total Non-Current Assets: | 5,486.04 | 4,992.84 |
| Total Current Assets: | 15,305.17 | 16,436.36 |
| Total Assets: | 20,791.21 | 21,429.20 |
| Total Equity: | 16,943.61 | 15,285.97 |
| Non-Current Liabilities: | 561.61 | 601.41 |
| Current Liabilities: | 3,285.99 | 5,541.82 |
| Total Equity and Liabilities: | 20,791.21 | 21,429.20 |
Dividend Recommendation
The Board of Directors recommended a final dividend of ₹1.25 per equity share (i.e., at 125% on the paid-up share capital) for the financial year ended March 31, 2026. The payment is subject to approval of shareholders at the ensuing Annual General Meeting.
Key Corporate Appointments
The board approved several significant personnel and governance changes at the May 13, 2026 meeting. The details are summarised below:
| Appointment/Change: | Details |
|---|---|
| Re-appointment – Ambarish Daga: | Re-appointed as Whole-time Director (Executive Director) for three years effective July 25, 2026, subject to Members' approval via Postal Ballot |
| Redesignation – Ambarish Daga: | Redesignated from "Joint CFO and Investor Relationship Officer" to "Investor Relationship Officer" |
| Re-appointment – Shruti Jatia: | Re-appointed as Whole-time Director (Executive Director) for three years effective September 2, 2026, subject to Members' approval via Postal Ballot |
| New Appointment – Darshana Sawant: | Appointed as Company Secretary and Compliance Officer effective May 13, 2026 |
| Cost Auditor – M/s. Poddar & Co.: | Appointed as Cost Auditors for FY2026-27 |
| Internal Auditor – M/s. RMJ & Associates LLP: | Appointed as Internal Auditors for FY2026-27 |
Mr. Ambarish Daga is a financial analyst with a background in operations management who manages overall corporate activities, and is not related to any director of the company. Mrs. Shruti Jatia has a career spanning over three decades in finance, accounts, and business operations, and is related to Mr. Anup Jatia, Non-Executive Director and Chairman of the company. Ms. Darshana Sawant (M. No.: A63226) is an Associate Member of the Institute of Company Secretaries of India with experience in compliance under the Companies Act, 2013, Listing Regulations, and other corporate laws.
Regulatory Disclosure and Company Background
In line with the company's Internal Code for Prevention of Insider Trading, the trading window for dealing in the company's securities had been closed from April 1, 2026, and will remain closed until 48 hours after the announcement of the financial results. The full format of the standalone and consolidated financial results is available on the BSE website at www.bseindia.com and on the company's website at www.blackrosechemicals.com . Black Rose Industries is headquartered at 145/A, Mittal Towers, Nariman Point, Mumbai – 400 021, with its factory located at Shree Laxmi Co-op. Industrial Estate Ltd., Hatkanangle, Dist. Kolhapur, Maharashtra. The company's CIN is L17120MH1990PLC054828, and its business activity falls within a single primary business segment of "Chemicals", with no separate reportable segments as per Ind AS 108.
Historical Stock Returns for Black Rose Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -6.43% | +6.85% | +15.68% | +15.68% | +15.68% | +15.68% |
How might the planned closure or sale of subsidiary B.R. Chemicals Co. Limited impact Black Rose Industries' consolidated balance sheet and future capital allocation strategy?
Given the ~15% year-on-year decline in standalone net profit despite a strong Q4 FY26 recovery, what operational or pricing factors could determine whether the company returns to revenue growth in FY27?
With current liabilities dropping sharply from ₹5,523 lakhs to ₹3,285 lakhs and operating cash flow turning strongly positive, how is management likely to deploy the improved liquidity — through capacity expansion, acquisitions, or higher shareholder returns?


































